about
Bone metastases: Causes, consequences and therapeutic opportunitiesThe beautiful history of pertuzumab.Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies.HER2 and hormone receptor-positive breast cancer--blocking the right targetTrastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factorsCancer immunotherapy does not increase the risk of death by COVID-19 in melanoma patients
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Eva Muñoz-Couselo
@en
Eva Muñoz-Couselo
@nl
type
label
Eva Muñoz-Couselo
@en
Eva Muñoz-Couselo
@nl
prefLabel
Eva Muñoz-Couselo
@en
Eva Muñoz-Couselo
@nl
P31
P496
0000-0001-7556-7608